These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Navigating the waters of pharmacy regulations in hospice care. Facing a common scenario: why can it be so difficult to obtain emergency medications? Greene R Caring; 2005 May; 24(5):6-12. PubMed ID: 15966151 [TBL] [Abstract][Full Text] [Related]
25. Another popular painkiller gets the government's hook. Querna E US News World Rep; 2005 Apr; 138(14):47. PubMed ID: 15839129 [No Abstract] [Full Text] [Related]
26. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns. Gilson AM; Joranson DE J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312 [TBL] [Abstract][Full Text] [Related]
27. Benzodiazepines and triplicate prescriptions: New York's experience. Uzych L Tex Med; 1991 Sep; 87(9):6. PubMed ID: 1759252 [No Abstract] [Full Text] [Related]
28. Summary and conclusions of a review of prescription drug diversion control methods. Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532 [No Abstract] [Full Text] [Related]
29. The pediatric research equity act and oncology. Hirschfeld S Pediatr Blood Cancer; 2004 Aug; 43(2):99-102. PubMed ID: 15236272 [No Abstract] [Full Text] [Related]
31. What is being done to address the new drug epidemic? Dekker AH J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827 [TBL] [Abstract][Full Text] [Related]
32. Guidelines for controlled substances. J Med Assoc State Ala; 1980 Oct; 50(4):12-7. PubMed ID: 7441067 [No Abstract] [Full Text] [Related]
33. Federal drug laws and CRNAs. Blumenreich GA; Stallone DR; Tobin MH AANA J; 1990 Aug; 58(4):253-4. PubMed ID: 2399777 [No Abstract] [Full Text] [Related]
34. Guidelines for prescribing of controlled substances. J Ky Med Assoc; 1981 Jan; 79(1):37-8. PubMed ID: 7217773 [No Abstract] [Full Text] [Related]
35. Management of medications revisited. Alt HA Tex Med; 1988 Nov; 84(11):66-70. PubMed ID: 3238618 [No Abstract] [Full Text] [Related]
36. The First Amendment and FDA restrictions on off-label uses: the call for a new approach. Leghorn J; Brophy E; Rother P Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466 [No Abstract] [Full Text] [Related]
38. New law preserves physician's rights to distribute drug samples. Mossinghoff GJ Colo Med; 1988 Oct; 85(18):392. PubMed ID: 3224496 [No Abstract] [Full Text] [Related]
39. Monitoring prescriptions for legitimacy. Vivian JC; Brushwood DB Am Pharm; 1991 Sep; NS31(9):32-5. PubMed ID: 1951039 [No Abstract] [Full Text] [Related]
40. Myth, mystique, and monopoly in the prescription of medicine. Sutliff LS Nurse Pract; 1996 Mar; 21(3):153-5. PubMed ID: 8710251 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]